"Executing differently takes courage" (5/5) - From managing global subsidiaries to walking the talk : when execution becomes personal
Épisode de Pharma Minds par Nathalie Lahitte · 17 août 2026 · 25 min
Organizations demand infinite growth in finite markets. Leaders are left at the crossroads of irreconcilable missions, balancing economic imperatives with the well-being of their teams. What happens when the equation simply has no solution? The cost of execution is sometimes your own breaking point.
Welcome to Pharma Minds, Summer Series "Executing differently takes courage". For this final episode of our miniseries, I wanted to explore what execution reveals about oneself at the deepest level. I chose to speak with Patrice because his journey shows what it concretely costs to actually do what you said you would do. Execution eventually ceases to be a professional requirement. It becomes a personal decision to put skin in the game, without a safety net, but with singular intention.
Patrice Zagame is the Founder and CEO of Eolias Health, an OTC lab for plant-based products aimed at the Brazilian market. After spending 35 years in the pharmaceutical industry and managing global subsidiaries for 16 years, he knows the weight of impossible contexts. From handling severe price cuts and sales force reductions in France to surviving executive burnout and ultimately funding his own venture, Patrice embodies the courage of leaving the comfort of a massive organization to truly walk the talk.
In this episode, we cover:
◾️The Impossible Equation : Balancing double-digit growth demands with saturated markets and massive price cuts.
◾️Choice Versus Chance : Why letting an organization dictate your pace can cost you the most crucial turns in your career.
◾️The Silent Break : Recognizing the boiling point of executive burnout and walking away to change the equation.
◾️Managing the Smartest Room : Stepping back from ego to lead experts who know more than you do.
◾️Walking the Talk : Leaving corporate security to fund an entrepreneurial venture from scratch.
Commitment is not a corporate posture. It is a daily decision renewed in the face of impossible contexts. At some point, managing the system is no longer enough.
👉 What is the hardest career pivot you have had to make to protect your own values? Let us know in the comments.
Strategies demand growth. Reality demands resilience.
If you want to follow the whole series, don't forget to subscribe.
-
This episode has been translated with the help of AI tools and edited to align with the editorial direction of this series.
Originally released on: 30/05/2023.
To listen to the original French version of this episode: https://smartlink.ausha.co/pharma-minds/patrice-zagame-senior-executive-ceo-fondateur-eolias-health-vibrer-avec-des-equipes-de-20-200-2000-personnes.
Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.
Autres épisodes de « Pharma Minds »
- #53 - Libérer du temps soignant : le pari d'un ingénieur à la Clinique Pasteur 19 octobre 2026
- [EXTRAIT] « On a toujours fait comme ça » : comment faire accepter le changement ? avec Loïc Lagarde 18 octobre 2026
- "Europe's Access Dilemma" (BONUS) - The Innovation Wave? Europe’s Payers Aren’t Convinced 12 octobre 2026
- "Europe's Access Dilemma" (5/5) - "Germany has a target on its back" What will Europe give up? 5 octobre 2026
- "Europe's Access Dilemma" (4/5) - Pharma Innovation: Your 8-Year Competitive Window Is Now Just 3 28 septembre 2026
- "Europe's Access Dilemma" (3/5) - MFN Is Already Changing Pharma Launch Strategy. Here’s How to Prepare. 21 septembre 2026
- "Europe's Access Dilemma" (2/5) - Europe Can't Pay More For Innovation: The Case For Co-developing With Asia 14 septembre 2026
- "Europe's Access Dilemma" (1/5) - Europe Is Losing Access to New Medicines. Here’s Why. 7 septembre 2026
- [Insights] Produits frontières : transformer la réglementation en avantage stratégique 2 septembre 2026
- "Executing differently takes courage" (4/5) - Biotech survival and resource allocation : why execution is about choosing what not to do 10 août 2026
- "Executing differently takes courage" (3/5) - Trusting the ground : navigating volatility, growth and partnerships across the EEMEA zone 3 août 2026
- "Executing differently takes courage" (2/5) - The Chinese pharma ecosystem : balancing systemic scale and constant reinvention 27 juillet 2026
- "Executing differently takes courage" (1/5) Transforming Vidal : how a 20-year vision turned a paper book into digital infrastructure 20 juillet 2026
- [Insights] Groupements de pharmacies : ce qu’il faut retenir du rapport IGF-IGAS, avec Hugues Villey Desmeserets 8 juillet 2026
- #52 - Prévention santé : le courage d'investir sans en récolter les fruits soi-même, avec Anne Beinier 22 juin 2026
À propos du podcast
Bienvenue dans Pharma minds, le podcast qui vous emmène dans une aventure captivante à travers la Pharma et la Santé d'aujourd'hui ! Je suis votre hôte, Nathalie Lahitte. Mon objectif ? Découvrir comment des personnalités influentes ont contribué à façonner ce secteur. À chaque épisode, nous…
Épisodes similaires
- Radio et DAB+ : y aura-t-il un jour de la vidéo FM ? – Ça marque ! Le podcast qui décrypte les stratégies de communication digitale et les innovations du marketing éditorial
- Webinaire / découvrir les ETF avec Amundi : comprendre, choisir et investir – Webinaire
- Arrêt maladie, Indemnités limitées à un an : ces enjeux RH que les DRH doivent poser sur la table du CoDir dès maintenant – Capital Humain – Travail, ressources humaines et santé mentale
- [AZIMUT ENTREPRENDRE | 1/3] - 15 000 abonnés sans montrer son visage - Safia Hadidi – Donne le Rythme
- Bénédicte Henry, sa foi, <br>ses convictions et engagements – Les rencontres du père Jacques Thierry
- 1000 ads en une semaine : comment Flytex scale ses ads Meta avec l'IA – Le Rendez-vous E-commerce
Tous les épisodes de Pharma Minds · Plus de podcasts Business